Want to take quizzes and track your credits?
Psychosocial consequences related to coronavirus disease 2019 (COVID-19) may place individuals at a heightened likelihood of opioid overdose or relapse.1,2 In 1 study,2 emergency medical services responses to opioid overdoses in Kentucky were increased in the early weeks following the COVID-19 state emergency declaration compared with the 52 previous days. This increased risk of opioid overdose may be particularly concerning among Black patients, who have been overrepresented in COVID-19–related infections, hospitalizations, and deaths, as well as associated socioeconomic consequences.3- 5 Given that emergency departments offer an opportune setting to initiate treatment, this study compared numbers of nonfatal, unintentional opioid-related opioid overdoses presenting to an urban emergency department during the early months of the pandemic relative to the previous year.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Taylor A. Ochalek, PhD, Virginia Commonwealth University C. Kenneth and Dianne Wright Center for Clinical and Translational Research, Richmond Academy of Medicine Bldg, 1200 E Clay St, Richmond, VA 23298 (email@example.com).
Accepted for Publication: August 25, 2020.
Published Online: September 18, 2020. doi:10.1001/jama.2020.17477
Author Contributions: Drs Ochalek and Gal had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Ochalek, Wills, Moeller.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Ochalek.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Ochalek, Gal.
Administrative, technical, or material support: Wills, Moeller.
Supervision: Ochalek, Cumpston, Moeller.
Conflict of Interest Disclosures: Dr Moeller reported consulting for Indivior PLC, Boehringer Ingelheim, and Astellas and receiving grant support from Indivior PLC and Nektar. No other disclosures were reported.
Funding/Support: This study was supported in part by National Institutes of Health research training grant NIDA T32 DA7027-44; National Institutes of Health grants UL1TR002649, U54DA038999, and NCI P30 CA016059/36; and funding from Indivior PLC and Virginia Catalyst.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
You currently have no searches saved.